JF
HRMY icon

Jump Financial’s Harmony Biosciences HRMY Stock Holding History

Jump Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.81M Buy
214,605
+135,097
+170% +$4.26M 0.06% 343
2026
Q1 		$2.23M Buy
79,508
+59,470
+297% +$1.95M 0.03% 613
2025
Q4 		$750K Buy
20,038
+6,214
+45% +$204K 0.01% 1107
2025
Q3 		$381K Buy
+13,824
New +$476K ﹤0.01% 1408
2024
Q2 		– Sell
-37,904
Closed -$1.27M – 2001
2024
Q1 		$1.27M Buy
+37,904
New +$1.22M 0.03% 662
2023
Q1 		– Sell
-41,900
Closed -$2.31M – 1782
2022
Q4 		$2.31M Buy
41,900
+7,800
+23% +$429K 0.12% 230
2022
Q3 		$1.51M Buy
+34,100
New +$1.66M 0.06% 465
2022
Q2 		– Sell
-51,786
Closed -$2.52M – 1791
2022
Q1 		$2.52M Buy
51,786
+34,106
+193% +$1.39M 0.11% 232
2021
Q4 		$754K Sell
17,680
-36,750
-68% -$1.46M 0.05% 486
2021
Q3 		$2.09M Buy
54,430
+24,955
+85% +$804K 0.15% 137
2021
Q2 		$832K Buy
29,475
+21,975
+293% +$659K 0.08% 319
2021
Q1 		$248K Buy
+7,500
New +$263K 0.02% 681

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's HRMY Position: Q2 2026 in Review

Jump Financial increased its Harmony Biosciences (HRMY) stake by 170% in Q2 2026, buying an estimated $4.26M and bringing the position to 214,605 shares worth $7.81M. The position accounts for 0.06% of the portfolio, ranked #343.

Jump Financial first reported a position in HRMY in Q1 2021 and has held it in 12 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jump Financial held 214,605 shares of Harmony Biosciences worth $7.81M as of Q2 2026.
  • Jump Financial bought 135,097 Harmony Biosciences shares in Q2 2026, an estimated $4.26M.
  • Harmony Biosciences made up 0.06% of Jump Financial's portfolio in Q2 2026, its #343 holding.
  • Jump Financial first reported a position in Harmony Biosciences in Q1 2021 and has held it in 12 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.